Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data

Author:

Weverling Flores1ORCID,Roeven Mieke2,Nijssen Clara1,Broers Annoek E. C.3,Dovern Elisabeth4ORCID,van Rhenen Anna1,Sluis Geerte van5,Hazenberg Carin L. E.6,Balen Peter van7,Kuipers Maria T.4,de Vooght Karen M. K.8,Morsink Linde6ORCID,Kuball Jürgen1ORCID,Nur Erfan4ORCID,de Witte Moniek A.1ORCID

Affiliation:

1. 1Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands

2. 2Department of Hematology, Radboud University Medical Center; Nijmegen, The Netherlands

3. 3Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands

4. 4Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands

5. 5Department of Hematology, Isala Hospital, Zwolle, The Netherlands

6. 6Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands

7. 7Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands

8. 8Central Diagnostic Laboratory, University Medical Center Utrecht, Utrecht, The Netherlands

Publisher

American Society of Hematology

Reference15 articles.

1. ABO-mismatched allogeneic hematopoietic stem cell transplantation;Worel;Transfus Med Hemother,2016

2. Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation;Aung;British journal of haematology,2013

3. Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question;Marco-Ayala;Bone Marrow Transplant,2021

4. Prevalence of pure red cell aplasia following major abo-incompatible hematopoietic stem cell transplantation;Zhu;Front Immunol,2022

5. Current use of and trends in hematopoietic cell transplantation in the United States;D'Souza;Biol Blood Marrow Transplant,2020

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Daratumumab;Reactions Weekly;2024-06-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3